Icon

Biocon Limited Stock Analysis and Price Target COMMON STOCK | Biotechnology | NSE

stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 235.35

0.00 (0.00)%

INR 272.96B

2.20M

INR 248.83(+5.73%)

N/A

Icon

BIOCON:NSE

Biocon Limited (INR)
COMMON STOCK | NSE
INR 235.35
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 272.96B

N/A

INR 235.35

Biocon Limited Stock Forecast

INR 248.83
(+5.73%)

Based on the Biocon Limited stock forecast from 4 analysts, the average analyst target price for Biocon Limited is INR 248.83 over the next 12 months. Biocon Limited’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Biocon Limited is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Biocon Limited’s stock price was INR 235.35. Biocon Limited’s stock price has changed by +0.15% over the past week, +1.91% over the past month and -16.59% over the last year.

No recent analyst target price found for Biocon Limited
No recent average analyst rating found for Biocon Limited

Company Overview Biocon Limited

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology...Read More

https://www.biocon.com

20th KM, Hosur Road, Bengaluru, India, 560100

16,545

March

INR

India

Adjusted Closing Price for Biocon Limited (BIOCON:NSE)

Loading...

Unadjusted Closing Price for Biocon Limited (BIOCON:NSE)

Loading...

Share Trading Volume for Biocon Limited Shares

Loading...

Compare Performance of Biocon Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOCON:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biocon Limited (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SYNGENE:NSE
Syngene International Limited 0.00 (0.00%) INR278.84B 55.58 25.90

ETFs Containing BIOCON

Symbol Name BIOCON's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biocon Limited (BIOCON:NSE) Stock

Based on ratings from 4 analysts Biocon Limited's stock is Hold . Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, 1 sell and 4 hold ratings.

BIOCON:NSE stock's dividend yield is 0.66%. Our analysis grades BIOCON:NSE stock's dividend yield at D+. This means that BIOCON:NSE stock's dividend yield is above 67% of the stocks in the Biotechnology sector in the NSE exchange. Based on this BIOCON:NSE may be a average dividend stock for its sector.

Based on targets from 4 analysts, the average taret price for BIOCON:NSE is INR 248.83 over the next 12 months. The maximum analyst target price is INR 273 while the minimum anlayst target price is INR 220.

BIOCON:NSE stock's Price/Earning ratio is 54.65. Our analysis grades BIOCON:NSE stock's Price / Earning ratio at F. This means that BIOCON:NSE stock's Price/Earning ratio is above 60% of the stocks in the Biotechnology sector in the NSE exchange. Based on this BIOCON:NSE may be a overvalued for its sector.

The last closing price of BIOCON:NSE's stock was INR 235.35.

The most recent market capitalization for BIOCON:NSE is INR 272.96B.

Based on targets from 4 analysts, the average taret price for BIOCON:NSE is projected at INR 248.83 over the next 12 months. This means that BIOCON:NSE's stock price may go up by +5.73% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...